pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
about
CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Myeloid cells - targets of medication in multiple sclerosis.Dendritic cells in central nervous system autoimmunity.Dendritic cell migration in health and disease.Autoimmunity in 2016.Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.
P2860
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@ast
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@en
type
label
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@ast
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@en
prefLabel
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@ast
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@en
P2093
P2860
P1476
pDC therapy induces recovery f ...... to sites of CNS inflammation.
@en
P2093
Carla Lippens
Dale Brighouse
Doron Merkler
Fernanda V Duraes
Juan Dubrot
Karin Steinbach
Nathalie Bendriss-Vermare
Shohreh Issazadeh-Navikas
Stephanie Hugues
P2860
P356
10.1016/J.JAUT.2015.08.014
P577
2015-09-01T00:00:00Z